ALX Oncology Realigns Executive Leadership Team
September 06, 2023 08:00 ET
|
ALX Oncology
Jason Lettmann appointed as Chief Executive OfficerDr. Jaume Pons transitions to Chief Scientific Officer SOUTH SAN FRANCISCO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings...
Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
April 19, 2023 09:00 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, April 19, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Catamaran Bio Announces Preclinical Data from Allogeneic CAR-NK Cell Therapy Pipeline for Solid Tumors to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023
April 11, 2023 08:00 ET
|
Catamaran Bio Inc.
Two allogeneic CAR-NK cell therapies demonstrate significant efficacy in tumor xenograft models Data underscore potential of TAILWIND® platform to create effective CAR-NK treatments for solid tumors ...
Cerevance Expands Series B Financing with Additional $51 Million
February 13, 2023 08:30 ET
|
Cerevance
Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETSseq platform CVN424 for Parkinson’s disease will advance to Phase 2 monotherapy study in Q2 2023 ...
Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced
January 05, 2023 08:00 ET
|
Volta Medical
New round of financing led by Vensana Capital will support technology platform expansion and further validating VX1, Volta’s Artificial Intelligence (AI) Decision-Support Software in improving...
MaxCyte Signs Strategic Platform License with Catamaran Bio to Support its CAR-NK Cell Therapy Programs
January 03, 2023 16:05 ET
|
MaxCyte, Inc
ROCKVILLE, Md., Jan. 03, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company providing enabling platform technologies to advance...
Carrick Therapeutics Closes Series C Financing
December 01, 2022 08:05 ET
|
CARRICK THERAPEUTICS LIMITED
Raised $25 million from a Series C financing Proceeds to advance development of first-in-class oncology pipeline across multiple indications DUBLIN, Ireland and BOSTON, Dec. 01, 2022 (GLOBE...
Cell and Gene Therapy Market Size to Surpass USD 93.78 BN by 2030
November 30, 2022 07:00 ET
|
Precedence Research
Ottawa, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Latest Research Study on “Cell and Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”. ...
Hatch félicite les gouvernements du Canada et de l'Allemagne pour leur leadership dans le cadre de l'accélération de la transition mondiale vers des énergies propres et pour leurs annonces à propos des marchés des métaux des batteries et de l'hydrogène
September 01, 2022 06:00 ET
|
Hatch Ltd
MISSISSAUGA, Ontario, 01 sept. 2022 (GLOBE NEWSWIRE) -- Cette semaine, les gouvernements du Canada et de l’Allemagne se sont réunis pour discuter de deux domaines-clés de coopération au moment où...
Hatch commends the governments of Canada and Germany for their leadership in accelerating the global clean energy transition with announcements for the battery metals and hydrogen markets
September 01, 2022 06:00 ET
|
Hatch Ltd
MISSISSAUGA, Ontario, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Last week, the governments of Canada and Germany came together to discuss two key areas of cooperation as we move towards a net-zero future,...